BGM Group Ltd. (BGM) stock
BGMNasdaqPharmaceutical PreparationsFiscal year ends September 30
$8.13+0.12 (+1.50%)
Close on Nov 17, 2026Market cap $3.26BP/E –Yield –
BGM cash
Cash and short-term investments held at the end of each period.
BGM's cash was $9.82M at Sep 30, 2025. For fiscal 2025 it was $9.82M, up 0.0% from the year before. The highest annual figure on record is $14.98M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $9.82M | +0.0% |
| FY2024 | Sep 30, 2024 | $9.82M | +15.8% |
| FY2023 | Sep 30, 2023 | $8.48M | -43.4% |
| FY2022 | Sep 30, 2022 | $14.98M | +18.8% |
| FY2021 | Sep 30, 2021 | $12.61M | +6.2% |
| FY2020 | Sep 30, 2020 | $11.87M | +158.3% |
| FY2019 | Sep 30, 2019 | $4.59M | -18.3% |
| FY2018 | Sep 30, 2018 | $5.62M | -4.2% |
| FY2017 | Sep 30, 2017 | $5.87M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $9.82M | +15.8% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $9.65M | -0.6% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $9.82M | -34.5% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $10.35M | -37.9% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $8.48M | -32.8% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $9.71M | -18.1% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $14.98M | +226.0% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $16.67M | +196.3% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $12.61M | +114.7% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $11.87M | – |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $4.59M | – |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $5.62M | – |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $5.87M | – |
See a number that looks wrong?